TD Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-31,961
Closed -$3.7M 1481
2023
Q3
$3.7M Buy
31,961
+330
+1% +$35.5K ﹤0.01% 792
2023
Q2
$3.25M Sell
31,631
-229,819
-88% -$24.2M ﹤0.01% 835
2023
Q1
$28.5M Sell
261,450
-70,517
-21% -$7.79M 0.03% 362
2022
Q4
$37.8M Buy
331,967
+300,353
+950% +$24.9M 0.05% 310
2022
Q3
$1.98M Buy
31,614
+581
+2% +$40.6K ﹤0.01% 1007
2022
Q2
$2.48M Sell
31,033
-2,308
-7% -$219K ﹤0.01% 948
2022
Q1
$3.51M Sell
33,341
-57
-0.2% -$5.55K ﹤0.01% 913
2021
Q4
$3.6M Sell
33,398
-1,489
-4% -$162K ﹤0.01% 962
2021
Q3
$3.82M Buy
34,887
+440
+1% +$45.7K ﹤0.01% 896
2021
Q2
$3.44M Buy
34,447
+1,782
+5% +$164K ﹤0.01% 929
2021
Q1
$3.01M Sell
32,665
-870
-3% -$73.4K ﹤0.01% 974
2020
Q4
$2.45M Sell
33,535
-13,928
-29% -$1.04M ﹤0.01% 982
2020
Q3
$3.69M Buy
47,463
+1,300
+3% +$89.4K 0.01% 786
2020
Q2
$2.57M Buy
+46,163
New +$1.97M ﹤0.01% 824
2014
Q3
Sell
-34,300
Closed -$543K 1357
2014
Q2
$543K Sell
34,300
-2,500
-7% -$35.7K ﹤0.01% 1008
2014
Q1
$556K Buy
+36,800
New +$416K ﹤0.01% 1009

Other funds holding HZNP